Clinical Trials in Philadelphia

Showing 2281-2300 of 17,926 trials

Vaccine Immune Recovery After Leukemia

NCT05622682

This observational study aims to assess recovery of the immune system and immunity to vaccine-preventable diseases in children, adolescents, and young adults who recently completed treatment for acute lymphoblastic leukemia (ALL). Several children's hospitals in the United States are participating in the study, which will enroll up to 100 pediatric participants. The study is intended to determine the rate of infection after leukemia treatment and to inform future studies and recommendations about whether children and adolescents who have leukemia should receive additional vaccine doses or boosters after treatment.

Acute Lymphoblastic Leukemia, Pediatric

Children's Hospital of Philadelphia89 participantsStarted Sep 2022

Chicago, Illinois, United States • Grand Rapids, Michigan, United States • Philadelphia, Pennsylvania, United States +3 more locations

Active Not RecruitingPhase 1< 1 mile

Study of Oral Epigallocatechin-3-gallate (EGCG) in IPF Patients

NCT05195918

The primary purpose of this multi-center, double-blind, placebo-controlled, dose-ranging Phase I study is to assess the safety of a purified from green tea, EGCG, in patients with idiopathic pulmonary fibrosis (IPF) as a potential novel treatment for pulmonary fibrosis.

Idiopathic Pulmonary Fibrosis

Hal Chapman50 participantsStarted Aug 2023

San Francisco, California, United States • Boston, Massachusetts, United States • Ann Arbor, Michigan, United States +4 more locations

Vaccine Immune Recovery After Leukemia

Study of Oral Epigallocatechin-3-gallate (EGCG) in IPF Patients

Find Trials by Condition in Philadelphia

Using FDG-PET/CT to Assess Response of Bone-Dominant Metastatic Breast Cancer, FEATURE Study

Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease

Rituximab and LMP-Specific T-Cells in Treating Pediatric Solid Organ Recipients With EBV-Positive, CD20-Positive Post-Transplant Lymphoproliferative Disorder

A Randomized Multicenter Study for Isolated Skin Vasculitis

Abatacept for the Treatment of Giant Cell Arteritis

A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures

Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients With Stage II-III Colorectal Cancer

Open-label Trial Characterizing the PK of 3 SC Olanzapine Extended-release Formulations in Participants With Schizophrenia/Schizoaffective Disorder

Testing the Use of BRAF-Targeted Therapy After Surgery and Usual Chemotherapy for BRAF-Mutated Colon Cancer

Pre-Symptomatic Study of Intravenous Onasemnogene Abeparvovec-xioi in Spinal Muscular Atrophy (SMA) for Patients With Multiple Copies of SMN2

An Efficacy and Safety Study of Basimglurant (NOE-101) in Patients With Trigeminal Neuralgia.

CSL312_3003 Safety and Pharmacokinetic Study in Subjects 2 to 11 Years of Age With Hereditary Angioedema

HKI-272 for HER2-Positive Breast Cancer and Brain Metastases

Study to Evaluate Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-291 Moves Through the Body in Adult Participants With Non-Hodgkin's Lymphoma

Collagen-targeted Positron Emission Tomography (PET) Imaging for Assessment of EGCG Effect

A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)

Dose Ranging, Switch Study of Islatravir (MK-8591) and Ulonivirine (MK-8507) Once-Weekly in Virologically-Suppressed Adults With Human Immunodeficiency Virus Type 1 (HIV-1) [MK-8591-013]

A Study of Mezagitamab in Adults With Primary Immunoglobulin A Nephropathy Receiving Stable Background Therapy